1. Background {#sec110995}
=============

*Streptococcus mutans* is the primary cause of dental caries; its pathogenicity is determined by ComCDE, a peptide-induced two-component signal transduction system (TCSTS), as this signal is involved in 4 vital physiological processes: competence development, bacteriocin synthesis, biofilm formation (dental plaque), and acid production ([@A22965R1]-[@A22965R7]). ComED consists of a response regulator, ComE; a histidine kinase sensor, ComD; while ComC is the competence-stimulating peptide (CSP) precursor ([@A22965R1]-[@A22965R4], [@A22965R8]-[@A22965R12]). By analogy to the model of *S. pneumonia*, CSP is firstly detected by ComD, then ComD activates its response regulator ComE, and finally ComE drives their downstream genes transcription ([@A22965R13], [@A22965R14]). In *S. mutans*, although ComCDE working mode is similar to that of *S. pneumonia*, its architecture appears to be very different. Firstly, ComCDE is organized in two operons (*comC* and *comED*), compared to one operon in *S. pneumonia* ([@A22965R8]-[@A22965R10], [@A22965R12]-[@A22965R14]), secondly, ComE binding sites in *S. pneumonia* work as direct repeat sequences, but in *S. mutans* have two patches, one patch of the direct repeat sequences can also work well ([@A22965R8]-[@A22965R10], [@A22965R12], [@A22965R13], [@A22965R15]).

Another protein closely related to ComCDE signal is ABC transporter ComAB, as this complex processes and secrets CSP ([@A22965R13], [@A22965R14]). In *S. mutans*, ComAB (SMU.1897 and SMU.1898) was designated as CslAB, in which CslA is an ATP-binding cassette transporter and CslB acts as an accessory; their genes are organized in operon *cslAB* ([@A22965R16]). Another homolog of ComAB (SMU.286 and SMU.287) was re-designated as NlmTE because it works in nonlantibiotic mutacin transport but not in genetic transformation ([@A22965R17]). Given that CslAB processes and secrets CSP from ComC (CSP precursor) and ComE binding sites have been found in all promoters of *comC*, *comED*, and *cslAB* ([@A22965R9]-[@A22965R12]), then all three operons driven by ComE, ComCDE would form a closed signal transduction.

Recently, it was reported that *comC* expression could be inhibited by difunctional regulator ComE, so ComCDE could be closed at its headstream lest it was amplified limitlessly ([@A22965R9], [@A22965R10], [@A22965R12], [@A22965R18]). Furthermore, to expound the work patterns of ComCDE, It is suggested that ComE functions in a concentration-dependent manner ([@A22965R9], [@A22965R10], [@A22965R12]). Obviously, it is necessary for ComCDE to be controlled precisely. CslAB determines extracellular CSP concentration since it is responsible for the processing and exporting of CSP ([@A22965R16], [@A22965R17]). Therefore, *cslAB* transcription was investigated to clarify the control principles of ComCDE. The promoter of *nlmAB* (PnlmAB) has a typical ComE binding site and is strictly regulated by ComCDE. As *nlmAB* transcription in vivo is clear ([@A22965R9], [@A22965R11], [@A22965R12], [@A22965R15]), it was used as a positive control.

2. Objectives {#sec110996}
=============

The binding properties of *cslAB* promoter (PcslAB) with ComE should be confirmed at first, then *cslAB* expression in vivo was investigated, and finally the role of CslAB in ComCDE signal would be confirmed.

3. Materials and Methods {#sec111002}
========================

3.1. Bacterial Strain and Medium {#sec110997}
--------------------------------

Bacterial strains were listed in [Table 1](#tbl28518){ref-type="table"}. *Escherichia coli* was cultivated in LB medium at 37°C, if needed, kanamycin (50 μg/mL), ampicillin (100 μg/mL), or isopropyl β-D-thiogalactopyranoside (1 mM) were added to the medium. *S. mutans* and its derivatives were cultivated in Todd-Hewitt broth medium with 0.3% yeast extract and 0.5% sucrose at 37°C, if required either 750 μg/mL kanamycin or 25 μg/mL erythromycin was supplied. *S.* *mutans* was transformed according to Li et al. protocol ([@A22965R2]). Todd-Hewitt broth medium (CM0189) was purchased from Oxoid Ltd, UK (http://www.oxoid.com/UK); the other reagents, if nonspecifically annotated, were obtained from Sangon Biotech., China (http://www.sangon.com).

###### Bacterial Strain and Vector

  Strain and Vector           Relevant Characteristics                                                                                    Reference (s)
  --------------------------- ----------------------------------------------------------------------------------------------------------- -----------------
  ***Escherichia coli***                                                                                                                  
  DH5α                        *supE44 lacU169 (80lacZ M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 luxS*                                    ([@A22965R19])
  BL21/p41ComE                BL21 (DE3) pLysS harbouring p41ComE to express fusion protein GST-ComE, Kan^R^                              ([@A22965R11])
  ***Streptococcusmutans***                                                                                                               
  WT                          Wild type UA159, Kan^S^ Erm^S^                                                                              ([@A22965R20])
  WT/p*A-LacZ*                WT with *LacZ* drove by promoter PnlmAB via single cross integration, Kan^R^                                ([@A22965R11])
  *ΔcomED/pA-LacZ*            as WT/*pA-LacZ*but *comED*was knocked out by double cross of *erm* cassette substitution, Kan^R^ Erm^R^     ([@A22965R11])
  *ΔcomC/pA-LacZ*             as WT/*pA-LacZ* but *comC* was knocked out by double cross of *erm* cassette substitution, Kan^R^ Erm^R^    ([@A22965R11])
  WT/*pAB-LacZ*               WT with *LacZ* drove by promoter PcslAB                                                                     This work
  *ΔcomED/pAB-LacZ*           as WT/*pAB-LacZ* but *comED* was knocked out by double cross of erm cassette substitution, Kan^R^ Erm^R^    This work
  *ΔcomC/pAB-LacZ*            as WT/*pAB-LacZ* but *comC* was knocked out by double cross of *erm* cassette substitution, Kan^R^ Erm^R^   This work
  **Vector**                                                                                                                              
  pUCm-T                      cloning T-vector, Amp^R^                                                                                    Sangon (SK2211)
  pLacZ                       a derivation of pSF151, *lacZ* was integrated in BamHI and SalI, Kan^R^                                     ([@A22965R11])

3.2. DNA Manipulation {#sec110998}
---------------------

Standard molecular cloning techniques were used. Restriction enzymes and T4 DNA ligase (EL0011) were obtained from Thermo Fisher Scientific Inc., China (http://www.thermo.com.cn). *Taq* DNA polymerase (R001B) was purchased from Takara Biotechnology (Dalian) CO., LTD., China (http://www.takara.com.cn). All plasmid extraction, DNA fragment purification, and DNA recovered from agarose gel were operated, respectively with SK8192, SK8142, and SK8132 kits obtained from Sangon Biotech., China.

3.3. Electrophoretic Mobility Shift Assay {#sec110999}
-----------------------------------------

ComE proteins were prepared according to Liu et al.'s protocol ([@A22965R11]). The primers for amplification of the promoters were synthesized in Sangon Biotech., China (summarized in [Table 2](#tbl28519){ref-type="table"}). Electrophoretic Mobility Shift Assay (EMSA) was set up according to Liu et al. and Jing et al. protocols ([@A22965R11], [@A22965R21]), but promoter DNA was fixed to 50 nM. In native PAGE (5% gel, V/V), 20 μL of binding mixture was directly loaded, then the gel was run in Tris-Glycine-EDTA buffer (25 mM) at 4°C. Finally, the gel was stained with SYBR Green I for 10 minutes. Hill equation was described with ([Equation 1](#EQ3097){ref-type="disp-formula"}):
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where 'n' is Hill coefficient and 'K~d~' is microscopic dissociation constant ([@A22965R12], [@A22965R22]). To calculate Hill equation, retarded and free DNAs were quantified by Scion Image Alpha 4.03, then log (DNA bound/free) were regressed against log \[ComE (nM)\] with Linear Fit of OriginPro 8.07.

###### Primer and DNA Fragment Amplified by Polymerase Chain Reaction ^[a](#fn27926){ref-type="table-fn"},[b](#fn27927){ref-type="table-fn"}^

  Primer                Primer Sequence (5\' → 3')                      Restriction Enzyme Site   Position Targeted, bp   Application
  --------------------- ----------------------------------------------- ------------------------- ----------------------- ---------------------------------------------
  **PcslAB-F**          5'-AACAGCAATATCGTAAACGG-3'                                                1784148 to 1784405      PcslAB promoter
  **PcslAB-B**          5'-GGAGTCTATCTGCGGAACAT-3'                                                                        
  **PnlmAB-F**          5'-AAATTAGCTGGTAATGATAGTT-3'                                              153650 to 153770        PnlmAB promoter
  **PnlmAB-R**          5'-GCAACCAACATCTTTAGTATAA-3'                                                                      
  **CslB-BamHI**        5'-ca[GGATCC]{.ul}AGACTGTTGCTCAGTATCTC-3'       [GGATCC]{.ul}             1786341 to 1787546      *cslB* for WT/*pAB-LacZ* construction
  **CslB-XbaI**         5'-gg[TCTAGA]{.ul}ACTATTGGTAAAGGCTAA-3'         [TCTAGA]{.ul}                                     
  **UpComED-F**         5'-GAACATAATTTACAGCGGTTCATA-3'                                            1796995 to 1797594      upstream fragment of *comED erm* cassette
  **UpComED-HindIII**   5'-gg[AAGCTT]{.ul}CAATGCGGTGGGAGAACT-3'         [AAGCTT]{.ul}                                     
  **DownComED-XhoI**    5'-ga[CTCGAG]{.ul}TTAGGCGGGCAATCATATTC-3'       [CTCGAG]{.ul}             1795545 to 1796323      downstream fragment of *comED erm* cassette
  **DownComED-R**       5'-AGCAGCCTCAATGGCATTAT-3'                                                                        
  **UpComC-F**          5'-ATCTGAACAAGCAGGGGAGA-3'                                                1794256 to 1795020      upstream fragment of *comC erm* cassette
  **UpComC-HindIII**    5'-gc[AAGCTT]{.ul}GTGTTTTTTTCATTTTATATCTCC-3'   [AAGCTT]{.ul}                                     
  **DownComC-XhoI**     5'-ta[CTCGAG]{.ul}TCCGGCTGTTTAACAGAAGTT-3'      [CTCGAG]{.ul}             1795105 to 1795947      downstream fragment of *comC erm* cassette
  **DownComC-R**        5'-GGCACAAAAGGAAGCTCAGA-3'                                                                        
  **Erm-HindIII**       5'-ga[AAGCTT]{.ul}CCGGGCCCAAAATTTGTTTGAT-3'     [AAGCTT]{.ul}             *erythromycin* gene     *erm* cassette construction
  **Erm-XhoI**          5'-aa[CTCGAG]{.ul}TCGGCAGCGACTCATAGAAT-3'       [CTCGAG]{.ul}                                     

^a^ Position targeted: physical location in the genome of *S. mutans* UA159 (AE014133).

^b^*Erythromycin* cassettes were recovered by PCR with primers upCom-F and downCom-R after the upstream, erm and downstream fragments were joined together.

3.4. Construction of S. mutans Derivations {#sec111000}
------------------------------------------

All primers used here were listed in [Table 2](#tbl28519){ref-type="table"}. WT/*pA-LacZ*, *ΔcomED/pA-LacZ*, and *ΔcomC/pA-LacZ*strains have been described before ([@A22965R11]). A *cslB* fragment was amplified by PCR from strain UA159 and then cloned into pLacZ to construct plasmid pCslB-LacZ. *S. mutans* UA159 was transformed with pCslB-LacZ to get WT/pAB-LacZ via single crossover in which *cslA*, *cslB* and *lacZ* were fused together. To knock out *comED* and *comC*, *erythromycin* cassettes of*comED* and *comC* were prepared according to Liu et al. method ([@A22965R11]). Then, they were transformed into WT/*pAB-LacZ* to knock out *comC* or *comED* by double crossover ([@A22965R15]).

3.5. Determination of Promoter Activity {#sec111001}
---------------------------------------

*Streptococcus mutans* overnight cultures were diluted 20-fold with fresh medium, if required CSP (1.0 μg/mL) and antibiotics were added, and then incubated for 2 or 3 hours at 37°C. Promoter activity was determined by β-galactosidase assay (LacZ) and calculated with the formula: \[1000 × A420 / reaction time (min)\] × OD675, in which the value of 420 nm absorbance for O-nitrophenyl-β-D-galactopyranoside color reaction and 675 nm absorbance for cell density were described with A420 and OD675 ([@A22965R23]).

4. Results {#sec111006}
==========

4.1. PcslAB, a Weak Promoter Responding to ComCDE {#sec111003}
-------------------------------------------------

EMSAs showed 3 retarded bands of BD1 to BD3 for PnlmAB and 2 bands of BD1 and BD2 for PcslAB. BD1 was firstly detected at 68.13 nM, ComE in lane 3 for PnlmAB and at 137.97 nM, ComE in lane 4 for PcslAB ([Figure 1](#fig21181){ref-type="fig"}). For PcslAB and PnlmAB, Hill coefficients were 0.6946 and 0.9356, respectively, while microscopic dissociation constants (K~d~) were 879.32 nM and 445.44 nM, respectively ([Figure 1](#fig21181){ref-type="fig"}). All data suggested that to bind with ComE, the affinity of PcslAB was weaker than that of PnlmAB.

![Electrophoretic Mobility Shift Assays (EMSAs) on PnlmAB and PcslAB](jjm-08-08-22965-g001){#fig21181}

EMSAs on PnlmAB (A) and PcslAB (B) both adopt 50 nM promoter DNAs. Lane 1 to 9: ComE concentration gradient (0, 34, 68, 138, 278, 555, 1111, 2223, and 4446 nM). NSD, BD, and FD: Non-specifically binding DNA, retarded DNA and free DNA. Hill coefficient and Kd were 0.9356 and 445.44 nM for PnlmAB, and 0.6946 and 879.32 nM for PcslAB.

4.2. PcslAB Partially Controlled by ComCDE {#sec111004}
------------------------------------------

PnlmAB was strictly controlled by ComCDE because the deletions of *comED* and *comC* both abolished PnlmAB activity, while exogenous CSP almost rescued the defects of *comC* but not the *comED*'s ([Figure 2](#fig21182){ref-type="fig"}: PnlmAB). PcslAB is partially controlled by ComCDE. Either *comED* or *comC* was knocked out, PcslAB activity decreased 34.66% and 17.64%, respectively but the leftovers were about 552.53 and 696.47 Miller units ([Figure 3](#fig21183){ref-type="fig"}: "-" of PcslAB). Exogenous CSP partly rescued the defects of *ΔcomED* and *ΔcomC* because PcslAB activity was recovered about 48.39% in *ΔcomE*D and 62.05% in *ΔcomC* against wild type ([Figure 2](#fig21182){ref-type="fig"}: "+" of PcslAB).

![PcslAB Partially Controlled by ComCDE](jjm-08-08-22965-i001){#fig21182}

![CslAB, a Stabilizer of ComCDE Signal on Its Expression](jjm-08-08-22965-i002){#fig21183}

PcslAB and PnlmAB show that strains are harboring *lacZ* drove by PcslAB and PnlmAB. Wild type, *ΔcomED* and *ΔcomC* are strain genetic background (wild type, knock-out of *comED* and *comC*). "-" and "+" show that the strains are cultivated in the medium without exogenous CSP or with 1.0 μg/mL CSP. Bars and error bars represent the mean ± SD of results in triplicate experiments.

4.3. CslAB, a Stabilizer of ComCDE Signal on Expression of Itself {#sec111005}
-----------------------------------------------------------------

When *S. mutans* cells were cultivated in the medium without exogenous CSP, PcslAB activity curve was steeper than that of PnlmAB and the increasing activity rate was 8.98 Miller units/minute for PcslAB and 0.71 Miller units/minute for PnlmAB. Obviously, PcslAB more effectively drove *cslAB* transcription than PnlmAB did for *nlmAB* ([Figure 3](#fig21183){ref-type="fig"}: "-" curves). When *S. mutans* cells were cultivated in the medium with 1.0 μg/mL CSP, the increasing activity rates were 24.38 Miller units/minute for PcslAB and 19.21 Miller units/minute for PnlmAB. In other words, PnlmAB activity increased 31.69 folds from 40th to 160th min (232.80 to 2974.94 Miller units), but PcslAB activity only increased 5.70 folds from 40th to 100th minutes (513.58 to 2365.39 Miller unit); PcslAB did not work as well as PnlmAB did ([Figure 3](#fig21183){ref-type="fig"}: "+" curves). These data together suggested that*cslAB* expression was obviously buffered by the change of PcslAB activity.

PcslAB and PnlmAB activities in strains of WT/*pAB-LacZ* and WT*/pA-LacZ* are determined by β-galactosidase activity and are shown with solid and dash line. Samples from the medium with 1.0 μg/mL CSP and without exogenous CSP are marked with "+" and "-". Promoter activity values and error bars represent the mean ± SD of results in triplicate experiments.

5. Discussion {#sec111007}
=============

ComCDE can be closed at its headstream because difunctional ComE can inhibit *comC* expression ([@A22965R9], [@A22965R11], [@A22965R12], [@A22965R19]), but *cslAB* transcription really offers ComCDE a more subtle mode to be regulated. Available data from [Figure 1](#fig21181){ref-type="fig"} show that PcslAB is a weak promoter responding to ComCDE and its binding with ComE is a negative cooperative reaction. We also know that the affinity of promoters of *comC*, *cslAB*, *comED,* and *comX*with ComE is decreasing in order and the binding of *comC* promoter with ComE is a strong positive cooperative reaction ([@A22965R9], [@A22965R10], [@A22965R12]). Furthermore, PcslAB is incompletely controlled by ComCDE and can work in an independent way ([Figures 2](#fig21182){ref-type="fig"} and [3](#fig21183){ref-type="fig"}). This evidence indicates that ComE can take more tasks, which must be done by two TCSTSs at least in *S. pneumonia*.

Moreover, it shows that CslAB offers ComCDE a unique regulation pattern. When ComCDE signal is weak, just like wild type cells were cultivated in the medium without exogenous CSP, PcslAB could also provoke *cslAB* transcription to ensure CSP secretion ([Figure 3](#fig21183){ref-type="fig"}). Obviously, PcslAB works in a mode independent of ComCDE ([Figures 1](#fig21181){ref-type="fig"} - [3](#fig21183){ref-type="fig"}). But when ComCDE signal is strong, as wild type cells were cultivated in the medium with 1.0 μg/mL CSP, PcslAB did not work as well as PnlmAB did, as PcslAB is a weak promoter responding to ComE ([Figures 1](#fig21181){ref-type="fig"} - [3](#fig21183){ref-type="fig"}). In this way, extracellular CSP gradient is maintained at a certain level, and all of these properties depend on PcslAB having a weak affinity with ComE and being partially controlled by ComCDE.

In *S. pneumonia,* the genes of competence development and bacteriocin production are organized in two regulons and their regulation starts by two separated primary signals ([@A22965R8], [@A22965R14], [@A22965R24], [@A22965R25]), but in *S. mutans* the same type of genes are packed into one regulon and the genes are differentially expressed relying on the interaction of their primary members ([@A22965R1]-[@A22965R4], [@A22965R9], [@A22965R16], [@A22965R26]). Clearly, CslAB unique expression pattern helps maintain extracellular CSP gradient, even though its mechanism is not completely obvious. We believe that its mechanism probably involves the following issues. First, the extracellular CSP detection is complex. In the studies of biofilm formation and competence development, a second CSP receptor was suggested because extracellular CSP could not be blocked completely when ComED was abolished ([@A22965R1], [@A22965R3]). Secondly, the intracellular CSP export is also complicated. CslAB is a specific apparatus to secrete CSP, at the same time NlmTE is a specific apparatus to secrete nonlantibiotic mutacin, but in vitro the peptidase domain of NlmT (SMU.286) and ComA-like (SMU.1881c) can cleave ComCs from other *Streptococcus*spp. ([@A22965R16], [@A22965R17], [@A22965R27]). Thirdly, ComE binding sites in the promoters of *comC* (142 bp), *comED* (321 bp), and *cslAB* (115 bp) are far from transcription start; it is possible that other unknown components control ComCDE signal ([@A22965R9]-[@A22965R12], [@A22965R18]). Fourthly, ComCDE signal and other signal transduction are closely intertwined. The former reports showed that competence development in *S. mutans* proceeded in multilevel control involved in other two-component signal and acid induction signal transduction ([@A22965R6], [@A22965R28]). Finally, we want to say that maybe there are housekeeping regulation mechanisms to affect the transcription of ComCDE primary members as that PcslAB activity is independent of ComCDE.
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